research
The Weak Bond Became Measurable by Shrinking Its Room
DNA nanocavities changed accessible volume instead of bulk dose and quantified millimolar-affinity interactions from tiny samples.
Summary
DNA nanocavities changed accessible volume instead of bulk dose and quantified millimolar-affinity interactions from tiny samples.
A preprint argues that weak molecular interactions become hard to measure when concentration is changed only by adding more molecules to a fixed volume. The researchers instead varied accessible nanoscale volume in DNA nanocavities, making local geometry a controlled experimental variable. They report quantifying an interaction on the order of 10 millimolar from femtomoles per well and using the geometry-sensitive readout to screen compounds that enhance weak associations. The broad paradigm claim and screening results are prepublication findings, not evidence of a clinical drug or universal assay.
Why it matters
DNA nanocavities changed accessible volume instead of bulk dose and quantified millimolar-affinity interactions from tiny samples.
Limits and context
- A preprint argues that weak molecular interactions become hard to measure when concentration is changed only by adding more molecules to a fixed volume.
- The broad paradigm claim and screening results are prepublication findings, not evidence of a clinical drug or universal assay.
Key claims
DNA nanocavities changed accessible volume instead of bulk dose and quantified millimolar-affinity interactions from tiny samples.
Qualification: A preprint argues that weak molecular interactions become hard to measure when concentration is changed only by adding more molecules to a fixed volume.
Evidence: source-2026-08-05-014
Sources
- arXiv preprint 2608.02865arXiv · primary research
Corrections
No corrections have been recorded for this story.